We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sun's Cardene ANDA Infringes EKR Patent: Judge

Law360 (April 1, 2009, 12:00 AM EDT) -- A judge has ruled that generic-drug maker Sun Pharmaceutical Industries Inc. would infringe a patent on EKR Therapeutics Inc.'s intravenous high blood pressure drug Cardene if it were allowed to market a generic version of the drug.

Judge Katharine S. Hayden of the U.S. District Judge for the District of New Jersey on Tuesday granted a motion for summary judgment of infringement by EKR, finding that Sun could not avoid infringing the patent by simply making a more concentrated drug than Cardene and requiring doctors to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.